Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 33

1.

Long-term Outcomes After Intraprocedural Aneurysm Rupture During Coil Embolization of Unruptured Intracranial Aneurysms.

Yamagami K, Hatano T, Nakahara I, Ishii A, Ando M, Chihara H, Ogura T, Suzuki K, Kondo D, Kamata T, Higashi E, Sakai S, Sakamoto H, Iihara K, Nagata I.

World Neurosurg. 2019 Oct 16. pii: S1878-8750(19)32653-1. doi: 10.1016/j.wneu.2019.10.038. [Epub ahead of print]

PMID:
31629140
2.

Thrombosis of Large Aneurysm Induced by Flow-Diverter Stent and Dissolved by Direct Factor Xa Inhibitor.

Higashi E, Hatano T, Ando M, Chihara H, Ogura T, Suzuki K, Yamagami K, Kondo D, Kamata T, Sakai S, Sakamoto H, Nagata I.

World Neurosurg. 2019 Nov;131:209-212. doi: 10.1016/j.wneu.2019.08.053. Epub 2019 Aug 20.

PMID:
31442658
3.

Development of Novel δ Opioid Receptor Inverse Agonists without a Basic Nitrogen Atom and Their Antitussive Effects in Mice.

Higashi E, Hirayama S, Nikaido J, Shibasaki M, Kono T, Honjo A, Ikeda H, Kamei J, Fujii H.

ACS Chem Neurosci. 2019 Sep 18;10(9):3939-3945. doi: 10.1021/acschemneuro.9b00368. Epub 2019 Aug 15.

PMID:
31397148
4.

Factors Associated with Postprocedural Diffusion-Weighted Imaging-Positive Lesions in Endovascular Treatment for Unruptured Cerebral Aneurysms.

Tokunaga K, Hatano T, Nakahara I, Ishii A, Higashi E, Kamata T, Funakoshi Y, Hashikawa T, Takita W, Chihara H, Ando M, Sadamasa N, Kitazono T, Nagata I.

World Neurosurg. 2019 Oct;130:e457-e462. doi: 10.1016/j.wneu.2019.06.114. Epub 2019 Jun 24.

PMID:
31247348
5.

Collagen vitrigel promotes hepatocytic differentiation of induced pluripotent stem cells into functional hepatocyte-like cells.

Nakai S, Shibata I, Shitamichi T, Yamaguchi H, Takagi N, Inoue T, Nakagawa T, Kiyokawa J, Wakabayashi S, Miyoshi T, Higashi E, Ishida S, Shiraki N, Kume S.

Biol Open. 2019 Jul 2;8(7). pii: bio042192. doi: 10.1242/bio.042192.

6.

Influence of GST polymorphisms on busulfan pharmacokinetics in Japanese children.

Nishikawa T, Yamaguchi H, Ikawa K, Nakayama K, Higashi E, Miyahara E, Abematsu T, Nakagawa S, Kodama Y, Tanabe T, Shigemi A, Shinkoda Y, Okamoto Y, Takeda Y, Kawano Y.

Pediatr Int. 2019 Jun;61(6):558-565. doi: 10.1111/ped.13859. Erratum in: Pediatr Int. 2019 Aug;61(8):841.

PMID:
30963629
7.

Discovery of δ Opioid Receptor Full Inverse Agonists and Their Effects on Restraint Stress-Induced Cognitive Impairment in Mice.

Hirayama S, Iwai T, Higashi E, Nakamura M, Iwamatsu C, Itoh K, Nemoto T, Tanabe M, Fujii H.

ACS Chem Neurosci. 2019 May 15;10(5):2237-2242. doi: 10.1021/acschemneuro.9b00067. Epub 2019 Apr 1.

PMID:
30913383
8.

A case of posterior reversible encephalopathy syndrome after surgical clipping of unruptured cerebral aneurysm.

Chihara H, Hatano T, Ando M, Takita W, Tokunaga K, Hashikawa T, Funakoshi Y, Kamata T, Higashi E, Nagata I.

World Neurosurg. 2019 Jan 17. pii: S1878-8750(19)30095-6. doi: 10.1016/j.wneu.2019.01.014. [Epub ahead of print] No abstract available.

PMID:
30660882
9.

Dural and Pial Arteriovenous Fistulas Connected to the Same Drainer in the Middle Cranial Fossa: A Case Report.

Funakoshi Y, Hatano T, Saka M, Ando M, Chihara H, Takita W, Tokunaga K, Hashikawa T, Kamata T, Higashi E, Nagata I.

World Neurosurg. 2018 Oct;118:47-52. doi: 10.1016/j.wneu.2018.06.214. Epub 2018 Jul 5.

PMID:
29981916
10.

Reversible cerebral vasoconstriction complicated with brain infarction immediately after carotid artery stenting.

Higashi E, Uwatoko T, Mizokami T, Sakaki Y, Sakata S, Sugimori H.

Interv Neuroradiol. 2018 Dec;24(6):688-692. doi: 10.1177/1591019918781778. Epub 2018 Jul 3.

PMID:
29969956
11.

Discovery of Peripheral κ-Opioid Receptor Agonists as Novel Analgesics.

Suzuki S, Sugawara Y, Inada H, Tsuji R, Inoue A, Tanimura R, Shimozono R, Konno M, Ohyama T, Higashi E, Sakai C, Kawai K.

Chem Pharm Bull (Tokyo). 2017;65(11):1085-1088. doi: 10.1248/cpb.c17-00555.

12.

C-Homomorphinan Derivatives as Lead Compounds to Obtain Safer and More Clinically Useful Analgesics.

Ishikawa K, Karaki F, Tayama K, Higashi E, Hirayama S, Itoh K, Fujii H.

Chem Pharm Bull (Tokyo). 2017;65(10):920-929. doi: 10.1248/cpb.c17-00385.

13.

cDNA cloning and expression of Contractin A, a phospholipase A2-like protein from the globiferous pedicellariae of the venomous sea urchin Toxopneustes pileolus.

Hatakeyama T, Higashi E, Nakagawa H.

Toxicon. 2015 Dec 15;108:46-52. doi: 10.1016/j.toxicon.2015.09.040. Epub 2015 Oct 3.

PMID:
26435342
14.

Naltrindole derivatives with fluorinated ethyl substituents on the 17-nitrogen as δ opioid receptor inverse agonists.

Nemoto T, Iihara Y, Hirayama S, Iwai T, Higashi E, Fujii H, Nagase H.

Bioorg Med Chem Lett. 2015 Aug 1;25(15):2927-30. doi: 10.1016/j.bmcl.2015.05.038. Epub 2015 May 22.

PMID:
26048798
15.

Hepatic microsomal UDP-glucuronosyltransferase (UGT) activities in the microminipig.

Higashi E, Ando A, Iwano S, Murayama N, Yamazaki H, Miyamoto Y.

Biopharm Drug Dispos. 2014 Sep;35(6):313-20. doi: 10.1002/bdd.1898. Epub 2014 May 21.

PMID:
24752421
16.

Discovery of 1-oxa-4,9-diazaspiro[5.5]undecane-based trisubstituted urea derivatives as highly potent soluble epoxide hydrolase inhibitors and orally active drug candidates for treating of chronic kidney diseases.

Kato Y, Fuchi N, Nishimura Y, Watanabe A, Yagi M, Nakadera Y, Higashi E, Yamada M, Aoki T, Kigoshi H.

Bioorg Med Chem Lett. 2014 Jan 15;24(2):565-70. doi: 10.1016/j.bmcl.2013.12.020. Epub 2013 Dec 10.

PMID:
24373724
17.

Discovery of 2,8-diazaspiro[4.5]decane-based trisubstituted urea derivatives as highly potent soluble epoxide hydrolase inhibitors and orally active drug candidates for treating hypertension.

Kato Y, Fuchi N, Saburi H, Nishimura Y, Watanabe A, Yagi M, Nakadera Y, Higashi E, Yamada M, Aoki T.

Bioorg Med Chem Lett. 2013 Nov 1;23(21):5975-9. doi: 10.1016/j.bmcl.2013.08.054. Epub 2013 Aug 20.

PMID:
24035338
19.

Human CYP2A6 is regulated by nuclear factor-erythroid 2 related factor 2.

Yokota S, Higashi E, Fukami T, Yokoi T, Nakajima M.

Biochem Pharmacol. 2011 Jan 15;81(2):289-94. doi: 10.1016/j.bcp.2010.09.020. Epub 2010 Sep 29.

PMID:
20887713
20.

Effects of the pathogenic water mold Saprolegnia ferax on survival of amphibian larvae.

Romansic JM, Diez KA, Higashi EM, Johnson JE, Blaustein AR.

Dis Aquat Organ. 2009 Feb 25;83(3):187-93. doi: 10.3354/dao02007.

21.

Genetic polymorphisms in the 5'-flanking region of human UDP-glucuronosyltransferase 2B7 affect the Nrf2-dependent transcriptional regulation.

Nakamura A, Nakajima M, Higashi E, Yamanaka H, Yokoi T.

Pharmacogenet Genomics. 2008 Aug;18(8):709-20. doi: 10.1097/FPC.0b013e32830500c9.

PMID:
18622263
22.

Molecular docking of porphyrins with cationic limbs on intramolecular G-quadruplex.

Ishikawa Y, Higashi E, Morioka H.

Nucleic Acids Symp Ser (Oxf). 2007;(51):247-8.

PMID:
18029679
23.

Human CYP2A6 is induced by estrogen via estrogen receptor.

Higashi E, Fukami T, Itoh M, Kyo S, Inoue M, Yokoi T, Nakajima M.

Drug Metab Dispos. 2007 Oct;35(10):1935-41. Epub 2007 Jul 23.

PMID:
17646279
24.

Inhibitory effects of neurotransmitters and steroids on human CYP2A6.

Higashi E, Nakajima M, Katoh M, Tokudome S, Yokoi T.

Drug Metab Dispos. 2007 Apr;35(4):508-14. Epub 2007 Jan 19.

PMID:
17237153
25.

Comprehensive evaluation of variability in nicotine metabolism and CYP2A6 polymorphic alleles in four ethnic populations.

Nakajima M, Fukami T, Yamanaka H, Higashi E, Sakai H, Yoshida R, Kwon JT, McLeod HL, Yokoi T.

Clin Pharmacol Ther. 2006 Sep;80(3):282-97.

PMID:
16952495
26.

Induction of human CYP2A6 is mediated by the pregnane X receptor with peroxisome proliferator-activated receptor-gamma coactivator 1alpha.

Itoh M, Nakajima M, Higashi E, Yoshida R, Nagata K, Yamazoe Y, Yokoi T.

J Pharmacol Exp Ther. 2006 Nov;319(2):693-702. Epub 2006 Jul 20.

PMID:
16857725
27.

Effects of nitrate and the pathogenic water mold Saprolegnia on survival of amphibian larvae.

Romansic JM, Diez KA, Higashi EM, Blaustein AR.

Dis Aquat Organ. 2006 Mar 2;68(3):235-43.

28.

A novel CYP2A6*20 allele found in African-American population produces a truncated protein lacking enzymatic activity.

Fukami T, Nakajima M, Higashi E, Yamanaka H, McLeod HL, Yokoi T.

Biochem Pharmacol. 2005 Sep 1;70(5):801-8.

PMID:
15993850
29.

Characterization of novel CYP2A6 polymorphic alleles (CYP2A6*18 and CYP2A6*19) that affect enzymatic activity.

Fukami T, Nakajima M, Higashi E, Yamanaka H, Sakai H, McLeod HL, Yokoi T.

Drug Metab Dispos. 2005 Aug;33(8):1202-10. Epub 2005 May 17.

PMID:
15900015
30.

Effect of acid-suppressive therapy on Helicobacter pylori production of interleukin-8 in the gastric mucosa.

Yoshinaga M, Ohtani A, Tsuruta S, Kato T, Higashi E, Yamada Y, Harada N, Nawata H.

Can J Gastroenterol. 2000 Apr;14(4):277-82.

PMID:
10799080
31.

Haptoglobin therapy for acute favism: a Japanese boy with glucose-6-phosphate dehydrogenase Guadalajara.

Ohga S, Higashi E, Nomura A, Matsuzaki A, Hirono A, Miwa S, Fujii H, Ueda K.

Br J Haematol. 1995 Feb;89(2):421-3.

PMID:
7873396
32.

Evaluation of nicotine, cotinine, thiocyanate, carboxyhemoglobin, and expired carbon monoxide as biochemical tobacco smoke uptake parameters.

Muranaka H, Higashi E, Itani S, Shimizu Y.

Int Arch Occup Environ Health. 1988;60(1):37-41.

PMID:
3258284
33.

[Electrophoretic and immunochemical characteristics of increased serum ceruloplasmin oxidases in patients with metastatic cancers (author's transl)].

Higashi E, Itani S, Muranaka H.

Rinsho Byori. 1980 Nov;28(11):1145-8. Japanese. No abstract available.

PMID:
7241818

Supplemental Content

Loading ...
Support Center